These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 663932)

  • 21. Malignant properties of sublines selected from a human bladder cancer cell line that contains an activated c-Ha-ras oncogene.
    Kovnat A; Buick RN; Choo B; De Harven E; Kopelyan I; Trent JM; Tannock IF
    Cancer Res; 1988 Sep; 48(17):4993-5000. PubMed ID: 3409229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody drug carrier for immunotherapy of superficial bladder cancer: ultrastructural studies.
    de Harven E; Fradet Y; Connolly JG; Hanna W; He S; Wang Y; Choi BC; McGroarty R; Bootsma G; Tilups A
    Cancer Res; 1992 Jun; 52(11):3131-7. PubMed ID: 1591726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers.
    Hopman AH; van Hooren E; van de Kaa CA; Vooijs PG; Ramaekers FC
    Mod Pathol; 1991 Jul; 4(4):503-13. PubMed ID: 1924281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells.
    Kotoh S; Naito S; Yokomizo A; Kumazawa J; Asakuno K; Kohno K; Kuwano M
    Cancer Res; 1994 Jun; 54(12):3248-52. PubMed ID: 8205547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent chromosome alterations in transitional cell bladder carcinomas.
    Matturri L; Lavezzi AM
    Eur J Histochem; 1992; 36(2):177-86. PubMed ID: 1380851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell cycles in two cell lines of human bladder carcinoma.
    Kato T; Irwin RJ; Prout GR
    Tohoku J Exp Med; 1977 Feb; 121(2):157-64. PubMed ID: 847742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Electron microscopic studies of in vitro cultivated human bladder cell lines: KK-47, KW-103, and HCV-29 (author's transl)].
    Kobayashi T
    Nihon Hinyokika Gakkai Zasshi; 1982 Mar; 73(3):294-307. PubMed ID: 7109399
    [No Abstract]   [Full Text] [Related]  

  • 28. Surface characteristics of malignant human urinary bladder epithelium studied with scanning electron microscopy.
    Nelson CE; Croft WA; Nilsson T
    Scand J Urol Nephrol; 1979; 13(1):31-42. PubMed ID: 419385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of cell lines derived from a multiply aneuploid human bladder transitional-cell carcinoma, UCRU-BL-13.
    Russell PJ; Wass J; Lukeis R; Garson OM; Jelbart M; Wills E; Philips J; Brown J; Carrington N; Vincent PC
    Int J Cancer; 1989 Aug; 44(2):276-85. PubMed ID: 2759734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identical genetic profiles in primary and metastatic bladder tumors.
    Summers JL; Falor WH; Ward RM; Fiorito J; Brezler MR; Abreu AJ
    J Urol; 1983 Apr; 129(4):827-8. PubMed ID: 6573516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study of cytokeratin in human normal bladder epithelium and bladder carcinoma cell lines].
    Sumi S; Kihara K; Kageyama Y; Higashi Y; Fukui I; Oshima H
    Hinyokika Kiyo; 1990 Aug; 36(8):903-6; Discussion 906-7. PubMed ID: 1700590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Proliferation apoptotic influence of crocin on human bladder cancer T24 cell line].
    Zhao P; Luo CL; Wu XH; Hu HB; Lv CF; Ji HY
    Zhongguo Zhong Yao Za Zhi; 2008 Aug; 33(15):1869-73. PubMed ID: 19007019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S; Abe T; Naito S; Kotoh S; Kumazawa J; Hipfner DR; Deeley RG; Cole SP; Kuwano M
    Br J Cancer; 1995 May; 71(5):907-13. PubMed ID: 7734314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
    Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
    Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior.
    Yu DS; Chen HI; Chang SY
    Urol Int; 2002; 69(2):129-35. PubMed ID: 12187044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multi-drug resistance of a doxorubicin-resistant bladder cancer cell line.
    Floyd JW; Lin CW; Prout GR
    J Urol; 1990 Jul; 144(1):169-71. PubMed ID: 1694250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24.
    Ning ZF; Huang YJ; Lin TX; Zhou YX; Jiang C; Xu KW; Huang H; Yin XB; Huang J
    J Int Med Res; 2009; 37(3):621-30. PubMed ID: 19589244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A squamous cell bladder carcinoma with karyotypic abnormalities reminiscent of transitional cell carcinoma.
    Lundgren R; Elfving P; Heim S; Kristoffersson U; Mandahl N; Mitelman F
    J Urol; 1989 Aug; 142(2 Pt 1):374-6. PubMed ID: 2746756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro study of the effect of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell lines.
    Matzkin H; Rangel MC; Soloway MS
    J Urol; 1992 Jun; 147(6):1671-4. PubMed ID: 1593718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor targeting of replication competent adenovirus enhances cytotoxicity in bladder cancer.
    van der Poel HG; Molenaar B; van Beusechem VW; Haisma HJ; Rodriguez R; Curiel DT; Gerritsen WR
    J Urol; 2002 Jul; 168(1):266-72. PubMed ID: 12050554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.